Tumorigenicity of RTK/RAS in urothelium.
Departments of Urology and Pathology, New York University School of Medicine, Veterans Affairs New York Harbor Healthcare System, Manhattan Campus, New York, NY, USA.
Xue-Ru
XR
Wu
Departments of Urology and Pathology, New York University School of Medicine, Veterans Affairs New York Harbor Healthcare System, Manhattan Campus, New York, NY, USA.
Cathy
C
Mendelsohn
Departments of Urology and Pathology, New York University School of Medicine, Veterans Affairs New York Harbor Healthcare System, Manhattan Campus, New York, NY, USA.
David J
DJ
DeGraff
RAS; RTK; bladder cancer; oncogene; tumorigenicity